GlassScriptPhysician profile
Lucille C Thomas
NPI 1114995768
$5,286.39
in general payments reported to CMS, 2019-2025
32 companies · $1,402 in 2025
The $1,402 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.21 · 2020: $482 · 2021: $923 · 2022: $748 · 2023: $759 · 2024: $912 · 2025: $1,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,975 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,974.82 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,739.34 | 2020-2025 | Vraylar, Ubrelvy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $465.21 | 2020-2025 | Caplyta |
| Sunovion Pharmaceuticals INC. | $457.98 | 2020-2022 | |
| Amgen INC. | $336.29 | 2020-2025 | Otezla, Repatha, Otezla |
| Bausch Health US, LLC | $270.59 | 2020-2024 | Aplenzin, Wellbutrin |
| Janssen Pharmaceuticals, INC | $201.07 | 2021-2024 | Spravato |
| Astellas Pharma US INC | $183.52 | 2025 | Veozah |
| Biohaven Pharmaceuticals, INC. | $174.52 | 2021 | |
| Lilly USA, LLC | $162.31 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $143.85 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Alkermes, INC. | $136.62 | 2020-2025 | Aristada, Lybalvi, Vivitrol |
| Indivior INC. | $118.17 | 2021-2025 | Sublocade |
| Lundbeck LLC | $95.68 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.95 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $73.35 | 2020-2024 | Qelbree |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.11 | 2023-2024 | Jardiance |
| Allergan, INC. | $65.04 | 2020 | |
| Axsome Therapeutics, INC. | $63.95 | 2024-2025 | Auvelity |
| Pfizer INC. | $52.88 | 2020-2023 | |
| Astrazeneca Pharmaceuticals LP | $50.70 | 2024-2025 | Airsupra, Breztri |
| Sage Therapeutics, LLC | $50.24 | 2024 | |
| Exact Sciences Corporation | $50.08 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $45.10 | 2022 | |
| Idorsia Pharmaceuticals US INC | $32.20 | 2022-2023 | Quviviq |
| Vertex Pharmaceuticals Incorporated | $31.34 | 2025 | |
| Gilead Sciences, INC. | $29.07 | 2019 | |
| Sumitomo Pharma America, INC. | $25.06 | 2023 | Latuda |
| Hologic Sales and Service, LLC | $21.67 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.40 | 2025 | Xifaxan |
| Vertiflex, INC. | $18.04 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $14.96 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucille Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.